Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NuVasive

This article was originally published in The Gray Sheet

Executive Summary

Privately held maker of minimally invasive spinal surgery systems raises $29.3 mil. in an equity financing led by William Blair Capital Partners, firm reports May 21. Proceeds will be used to support the launch of the company's recently approved products, including the INS-1 intraoperative nerve surveillance system, which gained 510(k) clearance in November 2000 (1"The Gray Sheet" Dec. 11, 2000, p. 22). The San Diego company's other products include SpineArc surgical guide frame and the Vector cannulae for less traumatic access to the spine. Other investors included Sofinov and Kleiner Perkins Caulfield & Byers

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel